This Article Full Text Full Text (PDF) All Versions of this Article: 16/12/2840    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pickett, C. A. Articles by Gutierrez-Hartmann, A. Search for Related Content PubMed PubMed Citation Articles by Pickett, C. A. Articles by Gutierrez-Hartmann, A.

Role of Specific Protein Kinase C Isozymes in Mediating Epidermal Growth Factor, Thyrotropin-Releasing Hormone, and Phorbol Ester Regulation of the Rat Prolactin Promoter in GH4/GH4C1 Pituitary Cells

Department of Medicine (C.A.P.), Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, Washington 98195-6426; Department of Medicine and of Biochemistry, Biophysics and Genetics (N.M., A.G.-H.), Program in Molecular Biology and Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado 80262; and Department of Molecular Cell Physiology (Y.A.), Tokyo Metropolitan Institute of Medical Science, Tokyo 113-8613, Japan

Address all correspondence and requests for reprints to: Cheryl A. Pickett, M.D., Ph.D., Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, Box 356426, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, Washington 98195-6426. E-mail: cpickett{at}u.washington.edu.

Epidermal growth factor (EGF) and TRH both produce enhanced prolactin (PRL) gene transcription and PRL secretion in GH4 rat pituitary tumor cell lines. These agents also activate protein kinase C (PKC) in these cells. Previous studies have implicated the PKC isozyme in mediating TRH-induced PRL secretion. However, indirect studies using phorbol ester down-regulation to investigate the role of PKC in EGF- and TRH-induced PRL gene transcription have been inconclusive. In the present study, we examined the role of multiple PKC isozymes on EGF- and TRH-induced activation of the PRL promoter by utilizing general and selective PKC inhibitors and by expression of genes for wild-type and kinase-negative forms of the PKC isozymes. Multiple nonselective PKC inhibitors, including staurosporine, bisindolylmaleimide I, and Calphostin C, inhibited both EGF and TRH induced rat PRL promoter activity. TRH effects were more sensitive to Calphostin C, a competitive inhibitor of diacylglycerol, whereas Go 6976, a selective inhibitor of Ca²⁺-dependent PKCs, produced a modest inhibition of EGF but no inhibition of TRH effects. Rottlerin, a specific inhibitor of the novel nPKC isozyme, significantly blocked both EGF and TRH effects. Overexpression of genes encoding PKCs , ßI, ßII, , , and failed to enhance either EGF or TRH responses, whereas overexpression of nPKC enhanced the EGF response. Neither stable nor transient overexpression of nPKC produced enhancement of EGF- or TRH-induced PRL promoter activity, suggesting that different processes regulate PRL transcription and hormone secretion. Expression of a kinase inactive nPKC construct produced modest inhibition of EGF-mediated rPRL promoter activity. Taken together, these data provide evidence for a role of multiple PKC isozymes in mediating both EGF and TRH stimulated PRL gene transcription. Both EGF and TRH responses appear to require the novel isozyme, nPKC, whereas nPKC may also be able to transmit the EGF response. Inhibitor data suggest that the EGF response may also involve Ca²⁺-dependent isozymes, whereas the TRH response appears to be more dependent on diacylglycerol.

This article has been cited by other articles:

				G. Vlotides, E. Siegel, I. Donangelo, S. Gutman, S.-G. Ren, and S. Melmed Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands Cancer Res., August 1, 2008; 68(15): 6377 - 6386. [Abstract] [Full Text] [PDF]

				M. McGahren-Murray, N. H.A. Terry, and K. Keyomarsi The Differential Staurosporine-Mediated G1 Arrest in Normal versus Tumor Cells Is Dependent on the Retinoblastoma Protein Cancer Res., October 1, 2006; 66(19): 9744 - 9753. [Abstract] [Full Text] [PDF]

				L. Luo, N. Yano, and J. Z. Q. Luo The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E889 - E899. [Abstract] [Full Text] [PDF]

				C. Klausen, T. Tsuchiya, J. P. Chang, and H. R. Habibi PKC and ERK are differentially involved in gonadotropin-releasing hormone-induced growth hormone gene expression in the goldfish pituitary Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1625 - R1633. [Abstract] [Full Text] [PDF]

				A. Sen, J. Browning, E. K. Inskeep, P. Lewis, and J. A. Flores Expression and Activation of Protein Kinase C Isozymes by Prostaglandin F2{alpha} in the Early- and Mid-Luteal Phase Bovine Corpus Luteum Biol Reprod, February 1, 2004; 70(2): 379 - 384. [Abstract] [Full Text] [PDF]